Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from InnoCare Pharma Ltd. ( (HK:9969) ) is now available.
InnoCare Pharma Ltd. has announced a board meeting scheduled for March 27, 2025, to consider and approve the annual financial results for the year ending December 31, 2024. This meeting is significant as it will impact the company’s financial disclosures and could influence stakeholder perceptions and market positioning.
More about InnoCare Pharma Ltd.
InnoCare Pharma Ltd. is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative drugs. The company operates in the healthcare industry, with a primary focus on creating treatments for cancer and autoimmune diseases.
YTD Price Performance: 42.65%
Average Trading Volume: 7,893,520
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$13.14B
See more insights into 9969 stock on TipRanks’ Stock Analysis page.